Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands

Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas

(2009) R Dahse et al.   BRITISH JOURNAL OF CANCER

Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2009) L. Jilaveanu et al.   CLINICAL CANCER RESEARCH

Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma

(2008) R Dahse et al.   BRITISH JOURNAL OF CANCER

Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma

(2008) Melonie A. Nance et al.   CANCER

Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment

(2008) Sae-Won Han et al.   LUNG CANCER

Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

(2008) Giulio Rossi et al.   LUNG CANCER

Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic and mutational analysis study

(2008) Ricardo S Macarenco et al.   MODERN PATHOLOGY

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE